Lb Pharmaceuticals announced it raised $6.93 Million in an initial filing from an offering of $10 Million
Nov 01, 2022•about 3 years ago
Amount Raised
$6.93 Million
New YorkHealth Care
Company Information
Company
LB Pharmaceuticals
Location
One Pennsylvania Plaza, Suite 1025
New York, New York, United States
About
LB Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of schizophrenia.
Our lead drug candidate is a second-generation antipsychotic and a potential first-in-class benzamide to enter the U.S. market. With robust clinical development underway and a focus on long-term patient outcomes, we aim to set a new standard of care for neuropsychiatric conditions.
New York